| # | Drug | Count |
|---|---|---|
| 0 | DOXORUBICIN | 44 |
| 1 | IFOSFAMIDE | 44 |
| 2 | IFOSFAMIDE FOR INJECTION | 44 |
| 3 | METHOTREXATE SODIUM | 41 |
| 4 | METHOTREXATE | 40 |
| 5 | CISPLATIN | 32 |
| 6 | CYCLOPHOSPHAMIDE | 32 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 9 | ETOPOSIDE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APROCITENTAN | 1 | 0.0455 |
| 1 | HISTAMINE | 1 | 0.0069 |
| 2 | DACTINOMYCIN | 10 | 0.0045 |
| 3 | LAROTRECTINIB | 4 | 0.0045 |
| 4 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 5 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 6 | IFOSFAMIDE FOR INJECTION | 44 | 0.0020 |
| 7 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0017 |
| 8 | POTASSIUM NITRATE, SODIUM FLUORIDE | 1 | 0.0016 |
| 9 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 68 |
| 1 | Platinum-based Drug [EPC] | 43 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 40 |
| 3 | Corticosteroid [EPC] | 39 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 38 |
| 5 | Topoisomerase Inhibitor [EPC] | 30 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 20 |
| 9 | Kinase Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 10 | 0.0045 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 3 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 4 | Topoisomerase Inhibitor [EPC] | 30 | 0.0004 |
| 5 | Alkylating Drug [EPC] | 68 | 0.0003 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 20 | 0.0003 |
| 7 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 9 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |